Study: Bae 2017, JAMA Dermatology
Phototherapy for Vitiligo: A Systematic Review and Meta-analysis
Citation
Bae JM, Jung HM, Hong BY, Lee JH, Choi WJ, Lee JH, Kim GM (2017). JAMA Dermatology. PubMed id 28355423.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Vitiligo, spread, starting age and treatment options Tier B thin
B 1,428 people in 35 prospective studies of generalised vitiligo (29 studies of narrowband UVB, 9 of PUVA); ancestry not given in the abstract (n=1428)
Systematic review and meta-analysis of single-arm response rates.
With narrowband UVB, at least mild repigmentation (25% or more) was seen in 74.2% of 232 patients at 6 months and 75.0% of 512 at 12 months; marked repigmentation (75% or more) in 19.2% of 266 at 6 months and 35.7% of 540 at 12 months. After 6 months or more, marked response on the face and neck was 44.2%, on the trunk 26.1%, on the limbs 17.3%, and none on the hands and feet. The authors recommend long-duration treatment.
As recorded in this card: Bae JM, Jung HM, Hong BY, Lee JH, Choi WJ, Lee JH, Kim GM (2017), JAMA Dermatology, [review]
Note: Single-arm studies, no untreated comparison; the abstract does not give participants' ancestry or skin types; funding not checked.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.